Digital PCR (dPCR) is a highly viable solution for copy number variation (CNV) detection, rare mutation detection and quantification, validation of NGS results, and applications alike. It offers significant advantages over quantitative PCR (qPCR) with regards to precision, reproducibility, and sensitivity, coupled with the ability to obtain absolute quantitative results without the need for standard curves. That is why, over the last years, many researchers have come to use dPCR, resulting in over 4500 publications until the previous year.

However, currently available solutions are either very complex to operate, or lack a scalability option for users with variable throughput and flexible workflow needs.
Unlike current systems relying on droplet generation, QIAGEN’s offering of fully integrated walkaway instrument options and multiple plate configurations with increased partitions can potentially solve throughput, speed, and usability challenges.

In this webinar, we’ll discuss:
• What improvements does QIAGEN’s dPCR solution offer over existing systems
• First insights into our entire dPCR product portfolio
• The menu of dPCR assays and their availability roadmap
About the speaker
Dr. Gerald Schock, Associate Director digital PCR instruments
Gerald Schock studied Biology and Biochemistry at the University of Mainz, Germany and at the University College of Wales, Aberystwyth, UK. He joined QIAGEN after receiving his Ph.D. in 1996, and has held positions in Sales, Regional Marketing, and Global Marketing, where he built up the epigenetics portfolio including Pyrosequencing instruments before assuming responsibility for the Life Science detection portfolio, and has now transitioned into digital PCR.
Dr. Michael Bussmann, Associate Director Global Product Management - dPCR
Michael Bussman received his Ph.D. degree in 2009 from the Forschungszentrum Jülich. Before joining QIAGEN in 2015, he held the product management position in MACHEREY-NAGEL, an innovator in chemical and biomolecular analysis products. At QIAGEN, he has held the position in Global Product Management in the assay technologies portfolio, including applied testing before assuming responsibility for the PCR Systems & Assays, and, most recently, digital PCR.
Date of recording:Saturday, May 15, 2021
Digital PCR
Molecular Biology Research